Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass

Obesity Surgery

Volumn 16, Issue 3, 2006, Pages 262-269

  Gómez Ambrosi, Javier ^a   Salvador, Javier ^a   Rotellar, Fernando ^a   Silva, Camilo ^a   Catalán, Victoria ^a   Rodríguez, Amaia ^a   Jesus Gil M ^a   Frühbeck, Gema ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Adiponectin; Adipose tissue; Morbid obesity; Roux en Y gastric bypass; SAA; Serum amyloid A; Weight loss

Indexed keywords

MESSENGER RNA; SERUM AMYLOID A;

ADIPOSE TISSUE; ADULT; ARTICLE; BARIATRIC SURGERY; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MORBID OBESITY; MORBIDITY; NUCLEOTIDE SEQUENCE; OMENTUM; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROUX Y ANASTOMOSIS; STOMACH BIOPSY; STOMACH BYPASS; STOMACH FUNDOPLICATION; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; ANASTOMOSIS, ROUX-EN-Y; FEMALE; GASTRIC BYPASS; HUMANS; MALE; OBESITY, MORBID; OMENTUM; POSTOPERATIVE PERIOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM AMYLOID A PROTEIN; WEIGHT LOSS;

EID: 33645289954     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206776116525     Document Type: Article

References (52)

1. Frühbeck G. The adipose tissue as a source of vasoactive factors. Curr Med Chem - Cardiovasc Hematol Agents 2004; 2: 197-208.
2. Gómez-Ambrosi J, Frühbeck G. Evidence for the involvement of resistin in inflammation and cardiovascular disease. Curr Diabetes Rev 2005; 1: 227-34.
3. Visser M, Bouter LM, McQuillan GM et al. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999; 282: 2131-5.
4. Fernández-Real JM, Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr Rev 2003; 24: 278-301.
5. Rosito GA, D'Agostino RB, Massaro J et al. Association between obesity and a prothrombotic state: the Framingham Offspring Study. Thromb Haemost 2004; 91: 683-9.
6. Cottam DR, Mattar SG, Barinas-Mitchell E et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg 2004; 14: 589-600.
7. Frühbeck G, Gómez-Ambrosi J, Muruzábal FJ et al. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am J Physiol Endocrinol Metab 2001; 280: E827-47.
8. Gómez-Ambrosi J, Catalán V, Diez-Caballero A et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004; 18: 215-7.
9. Baranova A, Collantes R, Gowder SJ et al. Obesity-related differential gene expression in the visceral adipose tissue. Obes Surg 2005; 15: 758-65.
10. Frühbeck G, Gómez Ambrosi J. Rationale for the existence of additional adipostatic hormones. FASEB J 2001; 15: 1996-2006.
11. Frühbeck G, Gómez-Ambrosi J. Control of body weight: a physiologic and transgenic perspective. Diabetologia 2003; 46: 143-72.
12. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92: 347-55.
13. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996; 26: 427-35.
14. Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000; 7: 64-9.
15. Ridker PM, Hennekens CH, Buring JE et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
16. Morrow DA, Rifai N, Antman EM et al. Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 2000; 35: 358-62.
17. Jousilahti P, Salomaa V, Rasi V et al. The association of C-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease - baseline findings of the PAIS project. Atherosclerosis 2001; 156: 451-6.
18. Delanghe JR, Langlois MR, De Bacquer D et al. Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 2002; 160: 471-6.
19. Sjöholm K, Palming J, Olofsson LE et al. A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A. J Clin Endocrinol Metab 2005; 90: 2233-9.
20. Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y - 500 patients: technique and results, with 3-60 month follow-up. Obes Surg 2000; 10: 233-9.
21. Hunter JG, Trus TL, Branum GD et al. A physiologic approach to laparoscopic fundoplication for gastroesophageal reflux disease. Ann Surg 1996; 223: 673-85.
22. Frühbeck G, Diez-Caballero A, Gómez-Ambrosi J et al. Disruption of the leptin-insulin relationship in obese men 24 hours after laparoscopic adjustable silicone gastric banding. Obes Surg 2002; 12: 366-71.
23. Frühbeck G, Diez-Caballero A, Gil MJ et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg 2004; 14: 606-12.
24. Frühbeck G, Rotellar F, Hernández-Lizoain JL et al. Fasting plasma ghrelin concentrations 6 months after gastric bypass are not determined by weight loss or changes in insulinemia. Obes Surg 2004; 14: 1208-15.
25. Das SK, Roberts SB, Kehayias JJ et al. Body composition assessment in extreme obesity and after massive weight loss induced by gastric bypass surgery. Am J Physiol Endocrinol Metab 2003; 284: E1080-8.
26. Collins AL, Saunders S, McCarthy HD et al. Within- and between-laboratory precision in the measurement of body volume using air displacement plethysmography and its effect on body composition assessment. Int J Obes 2004; 28: 80-90.
27. Fields DA, Higgins PB, Radley D. Air-displacement plethysmography: here to stay. Curr Opin Clin Nutr Metab Care 2005; 8: 624-9.
28. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969; 22: 158-61.
29. Matthews DR, Hosker JP, Rudenski AS et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
30. Friedewald WT, Levy RI, Fredrickson S. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of preparative ultra-centrifuge. Clin Chem 1972; 18: 499-502.
31. Gauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-40.
32. Gómez-Ambrosi J, Becerril S, Oroz P et al. Reduced adipose tissue mass and hypoleptinemia in iNOS deficient mice: effect of LPS on plasma leptin and adiponectin concentrations. FEBS Lett 2004; 577: 351-6.
33. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003; 112: 1785-8.
34. Frühbeck G, Salvador J. Role of adipocytokines in metabolism and disease. Nutr Res 2004; 24: 803-26.
35. Danesh J, Muir J, Wong YK et al. Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 1999; 20: 954-9.
36. van Dielen FM, van't Veer C, Schols AM et al. Increased leptin concentrations correlate with increased concentrations of inflammatory markers in morbidly obese individuals. Int J Obes 2001; 25: 1759-66.
37. Poitou C, Viguerie N, Cancello R et al. Serum amyloid A: production by human white adipocyte and regulation by obesity and nutrition. Diabetologia 2005; 48: 519-28.
38. Otero M, Lago R, Lago F et al. Leptin, from fat to inflammation: old questions and new insights. FEBS Lett 2005; 579: 295-301.
39. Rubino F, Gagner M, Gentileschi P et al. The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 2004; 240: 236-42.
40. Lannergard A, Larsson A, Kragsbjerg P et al. Correlations between serum amyloid A protein and C-reactive protein in infectious diseases. Scand J Clin Lab Invest 2003; 63: 267-72.
41. Holdstock C, Lind L, Engstrom BE et al. CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. Int J Obes 2005; 29: 1275-80.
42. Erren M, Reinecke H, Junker R et al. Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-63.
43. Ouchi N, Kihara S, Funahashi T et al. Obesity, adiponectin and vascular inflammatory disease. Curr Opin Lipidol 2003; 14: 561-6.
44. Ouchi N, Kihara S, Funahashi T et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 2003; 107: 671-4.
45. Soukas A, Cohen P, Socci ND et al. Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 2000; 14: 963-80.
46. Lin Y, Rajala MW, Berger JP et al. Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem 2001; 276: 42077-83.
47. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000; 21: 697-738.
48. Patriti A, Facchiano E, Sanna A et al. The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery. Obes Surg 2004; 14: 840-8.
49. Sjöström L, Lindroos AK, Peltonen M et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-93.
50. Williams IL, Chowienczyk PJ, Wheatcroft SB et al. Endothelial function and weight loss in obese humans. Obes Surg 2005; 15: 1055-60.
51. O'Brien KD, Brehm BJ, Seeley RJ et al. Diet-induced weight loss is associated with decreases in plasma serum amyloid a and C-reactive protein independent of dietary macronutrient composition in obese subjects. J Clin Endocrinol Metab 2005; 90: 2244-9.
52. Christou NV, Sampalis JS, Liberman M et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-23.